Ayuko Ota-Setlik, MS (she/her/hers)

Biomarker Clinical Assay Lead
Pfizer

Ayuko Ota-Setlik is a Biomarker Clinical Assay Lead at Pfizer. She has over 20 years of biotech and pharmaceutical R&D in the field of immunology and molecular biology, with expertise in infectious disease vaccine development and clinical research. Lead T-cell bifunctional clinical assay (ELISpot and Flow cytometry) development, validation and testing efforts to support the early clinical development of Ebola, Malaria, RSV and SARS-CoV2 vaccines. Current focus is on exploratory clinical research, precision medicine approaches and biomarker development across various inflammatory, infectious, cardiovascular and rare disease portfolios.

Disclosure information not submitted.

Presentation(s):

• Novel Alternatives to ELISPOT Assay for AAV Gene Therapy Clinical Studies

  Monday, April 24, 2023
  3:00 PM – 3:15 PM ET